SECsense Logo

Cyclo Therapeutics, Inc. 8-K Report: Key Insights on Stock & Warrants (Oct 2023)

$CYTHW
Form 8-K
Filed on: 2023-10-20
Source
Cyclo Therapeutics, Inc. 8-K Report: Key Insights on Stock & Warrants (Oct 2023)

Based on the provided XML section of the financial report, here are the key insights and information extracted:

  1. Entity Information:
  • Name: Cyclo Therapeutics, Inc.
  • CIK (Central Index Key): 0000922247
  • State of Incorporation: Nevada (NV)
  • SEC File Number: 000-25466
  • Employer Identification Number (EIN): 59-3029743
  • Address: 6714 NW 16th Street, Suite B, Gainesville, FL 32653
  • Phone Number: 386-418-8060
  1. Filing Information:
  • Form Type: 8-K (Current Report)
  • Filing Date: October 20, 2023
  1. Stock Information:
  • Common Stock: Par value of $0.0001 per share
  • Ticker Symbol: CYTH (NASDAQ)
  • Warrants to Purchase Common Stock: Ticker symbol for warrants is CYTHW (NASDAQ)
  1. Financial Context:
  • The reporting context specifies that the data pertains to common stock and warrants, indicating a focus on equity financing or capital structure.
  1. Date Range:
  • The report covers a specific date, October 20, 2023, without a broader reporting period indicated.
  1. XBRL Context:
  • The report utilizes XBRL (eXtensible Business Reporting Language) for structured financial data representation. The namespaces indicate compliance with various standards, including GAAP and SEC regulations.

Summary

Cyclo Therapeutics, Inc. filed an 8-K report on October 20, 2023, disclosing information related to its common stock and warrants. The company is located in Gainesville, Florida, and trades on NASDAQ under the symbols CYTH and CYTHW, respectively. The report indicates a par value of $0.0001 for the common stock, which is relevant for investors and analysts assessing the company's equity structure.